Literature DB >> 10391354

Management of infected aortic grafts: development of less invasive surgery using cryopreserved homografts.

P R Vogt1, M I Turina.   

Abstract

BACKGROUND: Aortic graft infection is associated with significant mortality and morbidity. Total graft replacement with homografts provides an effective treatment. Partial graft replacement at the site of infection may simplify the surgical procedure.
METHODS: Between January 1991 and December 1996, homografts were used in 18 patients (mean age, 61+/-12 years; range 41-85) with thoracic (4/18; 22%) or abdominal (14/18; 78%) aortic graft infection. Sepsis was present in 14 patients (78%); 6 (33%) had various aortic fistulae. Total graft replacement using homografts was performed in 14 (78%), and partial graft replacement at the site of infection in 4 patients (22%).
RESULTS: Hospital mortality was 11%. During the follow-up period of 22+/-15 months (range, 12-65) there was 1 infection and 1 homograft-related late death after complete homograft replacement, and 1 percutaneous vascular stent placement after partial graft replacement. No other instances of reinfection, suture line rupture or anastomotic aneurysms were observed.
CONCLUSION: Total graft replacement with homografts provides an effective treatment for infected aortic grafts. Partial graft replacement at the site of infection is feasible and safe.

Entities:  

Mesh:

Year:  1999        PMID: 10391354     DOI: 10.1016/s0003-4975(99)00357-4

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  6 in total

1.  In situ reconstruction with cryopreserved arterial allografts for management of mycotic aneurysms or aortic prosthetic graft infections: a multi-institutional experience.

Authors:  Wei Zhou; Peter H Lin; Ruth L Bush; Thomas T Terramani; John H Matsuura; Mitchell Cox; Eric Peden; Marlon Guerrero; Eric J Silberfein; Alan Dardik; David Rosenthal; Alan B Lumsden
Journal:  Tex Heart Inst J       Date:  2006

2.  A case of in-situ reconstruction with a rifampicin-bonded gelatin-sealed woven dacron graft for prosthetic graft infection with pseudoaneurysms after ascending aortic replacement for type a dissection.

Authors:  Yasunori Iida; Tsutomu Ito; Hiroto Kitahara; Motojiro Takebe; Atsushi Nemoto; Mai Nagumo; Kenji Saito; Takeshi Yamaya; Hiroshi Kanno; Takahiko Misumi
Journal:  Ann Vasc Dis       Date:  2014-02-04

3.  Complete graft dehiscence 8 months after repair of acute type A aortic dissection.

Authors:  Cathérine Gebhard; Patric Biaggi; Barbara E Stähli; Urs Schwarz; Christian Felix; Volkmar Falk
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-03

4.  Current options in prosthetic vascular graft infection: comparative analysis of 63 consecutive cases.

Authors:  Marcin Gabriel; Fryderyk Pukacki; Pawel Checinski; Grzegorz Oszkinis; Michal Stanisic; Maciej Zielinski; Katarzyna Pawlaczyk
Journal:  Langenbecks Arch Surg       Date:  2004-03-16       Impact factor: 3.445

5.  Contemporary outcome of the surgical management of prosthetic graft infection after a thoracic aortic replacement: is there a room to consider vacuum-assisted wound closure as an alternative?

Authors:  Tomoyuki Suzuki; Shunsuke Kawamoto; Naotaka Motoyoshi; Masatoshi Akiyama; Kiichiro Kumagai; Osamu Adachi; Yukihiro Hayatsu; Koki Ito; Satoshi Matsuo; Yoshikatsu Saiki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2014-07-20

Review 6.  Surgical management of infected thoracic aneurysms.

Authors:  Akihiko Usui
Journal:  Nagoya J Med Sci       Date:  2013-08       Impact factor: 1.131

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.